358 results match your criteria: ""University G. D'Annunzio" Foundation[Affiliation]"
Inflamm Res
January 2025
Department of Pharmacy, University "G. d'Annunzio" of Chieti-Pescara, 66100, Chieti, Italy.
Objective: This study explores whether hyaluronic acid (HA) of different molecular weights and collagen, given their role in tendon extracellular matrix maintenance, have a synergistic effect on human tendon-derived cells, with the aim to improve the treatment of tendinopathy.
Material: Human monocytes (CRL-9855™) and primary Achilles tendon-derived cells.
Treatment: The collagen/HA ratio was based on the formulation of the commercial food supplement TendoGenIAL™.
Scand J Med Sci Sports
October 2024
The August Krogh Section for Human Physiology, Department of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen, Denmark.
Skeletal muscle mass plays a pivotal role in metabolic function, but conditions such as bed rest or injury often render resistance training impractical. The beta-adrenergic receptor has been highlighted as a potential target to promote muscle hypertrophy and treat atrophic conditions. Here, we investigate the proteomic changes associated with beta-adrenergic-mediated muscle hypertrophy, using resistance training as a hypertrophic comparator.
View Article and Find Full Text PDFCancers (Basel)
September 2024
Department of Translational Medical Sciences, University of Campania Luigi Vanvitelli, 80131 Naples, Italy.
Eur J Intern Med
September 2024
GVM Care & Research, Maria Cecilia Hospital, Cotignola Ravenna, Italy. Electronic address:
Brain Commun
August 2024
Division of Clinical Geriatrics, Center for Alzheimer Research, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, 171 77 Stockholm, Sweden.
J Neurol
October 2024
Department of NEUROFARBA, University of Florence, Careggi University Hospital, Florence, Italy.
Neuroimage Clin
September 2024
Department of Neuroscience, Imaging, and Clinical Sciences, University "G. d'Annunzio" of Chieti-Pescara, Italy; Institute for Advanced Biomedical Technologies (ITAB), "G. d'Annunzio" University, Chieti-Pescara, Italy; UdA-TechLab, Research Center, University "G. d'Annunzio" of Chieti-Pescara, Chieti, Italy.
Background: Chronic Low Back Pain (cLBP) poses a significant health challenge, leading to functional disability and reduced quality of life. Osteopathic Manipulative Treatment (OMT) is emerging as a therapeutic option for cLBP, but the brain mechanisms underlying its analgesic effect remain unclear.
Materials And Methods: Thirty cLBP patients were randomly exposed to either four weekly sessions of OMT (N=16) or Sham treatment (N=14).
Brain Sci
August 2024
Department of Psychology, University "G. d'Annunzio", 66100 Chieti Scalo, Italy.
Sensory-motor integration represents a complex process requiring proper orchestration among multiple sources of sensory information to ensure the best task-related motor output [...
View Article and Find Full Text PDFBrain Sci
July 2024
Department of Engineering and Geology, University "G. d'Annunzio" of Chieti-Pescara, 65127 Pescara, Italy.
Motor impairment is a common issue in stroke patients, often affecting the upper limbs. To this standpoint, robotic neurorehabilitation has shown to be highly effective for motor function recovery. Notably, Machine learning (ML) may be a powerful technique able to identify the optimal kind and intensity of rehabilitation treatments to maximize the outcomes.
View Article and Find Full Text PDFKidney Blood Press Res
October 2024
Research and Development, Iperboreal Pharma, Pescara, Italy.
Introduction: Peritoneal ultrafiltration (PUF) has been proposed as an additional therapeutic option for refractory congestive heart failure (RCHF) patients. Despite promising observational studies and/or case report results, limited clinical trial data exist, and so far, PUF solutions remain only indicated for chronic kidney diseases. In this article, we described a multicenter, randomized, controlled, unblinded, adaptive design clinical trial, about to start, investigating the effects of PolyCore™, an innovative PUF solution, in the treatment of RCHF patients.
View Article and Find Full Text PDFInt Nurs Rev
August 2024
Department of Nursing, Midwifery and Health, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, UK.
Aims: To profile the characteristics of nurses with varying levels of vaccine hesitancy toward the COVID-19 and influenza vaccines.
Background: In many countries across the world, healthcare workers, and nurses in particular, display significant reluctance toward COVID-19 and influenza vaccines due to concerns about safety, distrust in healthcare policies, and media influences. To address this, a proposed approach involves profiling nurses to tailor vaccination campaigns and to improve acceptance rates and public health outcomes.
JACC Adv
July 2024
Clinical and Rehabilitation Unit, San Filippo Neri Hospital, Rome, Italy.
Entropy (Basel)
July 2024
Department of Engineering and Geology, University G. D'Annunzio of Chieti-Pescara, 65127 Pescara, Italy.
A stroke represents a significant medical condition characterized by the sudden interruption of blood flow to the brain, leading to cellular damage or death. The impact of stroke on individuals can vary from mild impairments to severe disability. Treatment for stroke often focuses on gait rehabilitation.
View Article and Find Full Text PDFInt J Mol Sci
July 2024
Paediatric Department, University of Chieti "G. D'Annunzio", 66100 Chieti, Italy.
Skin lesions are frequently observed in children with rheumatic diseases, particularly in conditions such as IgA vasculitis (IgAV) and Kawasaki disease (KD). In paediatric vasculitis, the presence of skin lesions serves as an early indicator, emphasising the importance of timely diagnosis to prevent complications, such as cardiac or renal involvement. Conversely, autoinflammatory disorders like juvenile systemic lupus erythematosus (SLE) and juvenile dermatomyositis (DM) may manifest with cutaneous manifestations either at the onset of disease or during its progression.
View Article and Find Full Text PDFMult Scler
July 2024
IRCCS Mondino Foundation, Pavia, Italy.
Background: Multiple sclerosis (MS) is frequently accompanied by comorbid conditions.
Objectives: This study aimed to determine the prevalence of key comorbid conditions in people with multiple sclerosis (pwMS) and assess their impact on quality of life and work-related activities.
Methods: A cross-sectional study involving 755 pwMS from two third-level Italian MS centers was conducted.
J Neurol
August 2024
Department of NEUROFARBA, University of Florence, Careggi University Hospital, Florence, Italy.
Objectives: We investigated the occurrence and relative contribution of relapse-associated worsening (RAW) and progression independent of relapse activity (PIRA) to confirmed disability accrual (CDA) and transition to secondary progression (SP) in relapsing multiple sclerosis (MS).
Methods: Relapsing-onset MS patients with follow-up > / = 5 years (16,130) were extracted from the Italian MS Registry. CDA was a 6-month confirmed increase in Expanded Disability Status Scale (EDSS) score.
Vaccines (Basel)
May 2024
Institute of Biostructures and Bioimaging, National Research Council, 80145 Naples, Italy.
Eur J Transl Myol
May 2024
Department of Biomedical Sciences, University of Padova, Padova, Italy; CIR MYO - Interdepartmental Research Centre of Myology, University of Padua, Italy; Armando & Carmela Mioni-Carraro Foundation for Translational Myology, Padua.
It is with great sadness that we learned of the passing of Prof. Dr. Dr.
View Article and Find Full Text PDFActa Neuropsychiatr
August 2024
Brain and Cognition Discovery Foundation, Toronto, ON, Canada.
Background: Individuals who have recovered from the acute stage of SARS-CoV-2 infection may be at risk of developing post-COVID-19 condition (PCC), characterised by a spectrum of persisting, non-specific, and functionally impairing symptoms across multiple organ systems. Obesity has been implicated as a risk factor for PCC, mediated by chronic systemic inflammation. The foregoing has also been separately reported to mediate cognitive dysfunction in PCC.
View Article and Find Full Text PDFAdv Ther
May 2024
Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.
Introduction: To date, there are no therapeutics that have gained regulatory approval by the United States Food and Drug Administration (FDA) for the treatment of post-COVID-19 condition (PCC), a debilitating condition characterized by cognitive impairment and mood symptoms. Additionally, persistent inflammation, metabolic dysfunction, and risks associated with an elevated body mass index (BMI) have been observed. Herein, we aimed to assess the efficacy of vortioxetine in improving depressive symptoms among individuals with PCC, as modulated by inflammation, metabolic dysfunction, and BMI.
View Article and Find Full Text PDFCont Lens Anterior Eye
June 2024
Department of Movement, Human and Health Sciences, University of Rome "Foro Italico", Rome, Italy; IRCCS Santa Lucia Foundation Rome, Italy.
A common non-spectacle strategy to correct presbyopia is to provide simultaneous images with multifocal optical designs. Understanding the neuroadaptation mechanisms behind multifocal devices usage would have important clinical implications, such as predicting whether patients will be able to tolerate multifocal optics. The aim of this study was to evaluate the brain correlates during the initial wear of multifocal contact lenses (CLs) using high-density visual evoked potential (VEP) measures.
View Article and Find Full Text PDFInt J Mol Sci
February 2024
Stem Cell Transplantation and Cellular Therapy Laboratory, Paediatric Onco-Haematology Division, Regina Margherita Childrens' Hospital, City of Health and Science of Turin, 10126 Turin, Italy.
The Second International StemNet (Federation of Stem Cell Research Associations) meeting took place on 18-20 October 2023 in Brescia (Italy), with the support of the University of Brescia and the Zooprophylactic Institute of Lombardy and Emilia Romagna. The program of the meeting was articulated in nine sections: (1) Biomedical Communication in Italy: Critical Aspects; (2) StemNet Next Generation Session; (3) Cell-Free Therapies; (4) Tips and Tricks of Research Valorisation; (5) Stem Cells and Cancer; (6) Stem Cells in Veterinary Applications; (7) Stem Cells in Clinical Applications; (8) Organoids and 3D Systems; (9) induced pluripotent stem cells (iPCS) and Gene Therapy. National and International speakers presented their scientific works, inspiring debates and discussions among the attendees.
View Article and Find Full Text PDFEur J Transl Myol
February 2024
Department of Biomedical Sciences, University of Padova, Padua, Italy; Interdepartmental Research Centre of Myology, University of Padova, Padua, Italy; Armando Carraro & Carmela Mioni-Carraro Foundation for Translational Myology, Padua.
During the 2023 Padua Days on Muscle and Mobility Medicine the 2024 meeting was scheduled from 28 February to 2 March 2024 (2024Pdm3). During autumn 2023 the program was expanded with Scientific Sessions which will take place over five days (in 2024 this includes February 29), starting from the afternoon of 27 February 2024 in the Conference Rooms of the Hotel Petrarca, Thermae of Euganean Hills (Padua), Italy. As per consolidated tradition, the second day will take place in Padua, for the occasion in the Sala San Luca of the Monastery of Santa Giustina in Prato della Valle, Padua, Italy.
View Article and Find Full Text PDF